上海医药 (601607.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(上海医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 70,152,787,484.98260,295,088,943.53197,508,314,193.06132,592,157,323.3766,226,461,496.33231,981,299,764.51174,611,918,877.50111,707,464,327.6456,898,217,119.51
 营业利润(元) 2,414,682,250.747,667,234,704.326,555,955,096.954,558,084,231.872,490,594,009.009,014,650,389.277,621,339,794.485,799,204,554.841,995,123,812.46
 利润总额(元) 2,416,700,316.257,054,296,738.486,518,995,175.954,533,792,505.392,491,896,591.338,808,353,281.137,567,902,191.225,757,962,951.481,986,577,269.94
 净利润(元) 1,865,572,336.295,166,570,284.264,953,768,221.763,417,001,019.981,953,045,694.636,992,014,768.555,984,250,349.974,564,219,430.251,532,331,542.58
 归属于母公司股东的净利润(元) 1,542,277,554.183,767,999,581.183,796,770,660.152,609,821,842.281,517,649,326.445,617,152,003.014,813,906,174.073,695,606,535.711,251,018,657.92
盈利能力:
 销售毛利率(%) 11.4412.0412.1312.8713.0413.1412.9913.4512.88
 销售净利率(%) 2.661.982.512.582.953.013.434.092.69
 净资产收益率(%) 2.235.565.643.932.28----
 总资产报酬率ROA(%) 1.324.163.762.651.50----
 投入资本回报率ROIC(%) 1.263.283.282.281.335.774.983.851.32
营运能力:
 存货周转率(次) 1.886.445.473.792.00----
 应收账款周转率(次) 0.903.732.661.860.96----
 总资产周转率(次) 0.331.270.970.660.34----
偿债能力:
 资产负债率(%) 62.2562.1162.4062.9961.2360.6360.6359.5459.14
 股东权益比率(%) 32.2232.3332.1431.5833.2833.8534.0034.9135.45
 已获利息倍数(倍) 7.455.756.656.866.967.718.599.876.54
 流动比率 1.341.331.341.331.381.351.371.401.42
 速动比率 1.011.001.011.031.041.001.081.091.11
发展能力:
 营业收入增长率(%) 5.9312.2113.1118.7016.397.498.476.1510.27
 营业利润增长率(%) -3.05-14.95-13.98-21.4024.839.8612.0610.88-33.31
 税后利润增长率(%) 1.62-32.92-21.13-29.3821.3110.287.353.58-40.99
 净资产增长率(%) 2.182.183.533.116.2735.8736.0036.9136.04
 总资产增长率(%) 5.526.989.5213.9813.1921.2319.1818.1316.66

前瞻产业研究院